Edesa Biotech, Inc. (EDSA) Capital expenditures 2013–2023
Edesa Biotech, Inc. (EDSA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2023 · since FY2013: $9,541 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $5,656 | -8.0% |
| FY2021 | $6,146 | +26.6% |
| FY2020 | $4,856 | — |
| FY2018 | $6,869 | -97.7% |
| FY2017 | $302,733 | -24.7% |
| FY2016 | $402,271 | +46.5% |
| FY2015 | $274,589 | -1.6% |
| FY2014 | $279,065 | +2824.9% |
| FY2013 | $9,541 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice